Article info
PDFRecommendation
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases
- Correspondence to Professor Jonathan Kay, Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester, MA 01605, USA; jonathan.kay{at}umassmemorial.org
Citation
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases
Publication history
- Received June 15, 2017
- Revised July 20, 2017
- Accepted August 12, 2017
- First published September 2, 2017.
Online issue publication
February 17, 2018
Article Versions
- Previous version (12 January 2018).
- Previous version (12 January 2018).
- Previous version (12 January 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.